(Q74754732)

English

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK)

scientific article published on 01 May 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

phase III clinical trial

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M M Borner

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Castiglione

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Bacchi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

W Weber

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Herrmann

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M F Fey

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

O Pagani

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Leyvraz

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R Morant

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

B Pestalozzi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S Hanselmann

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A Goldhirsch

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

535-541

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of doxifluridine and fluorouracil in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple confirmatory trials. How can additional studies be of value?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008270916325

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008270916325

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9653495%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74754732&oldid=2223615098"